Generated by Meeveem AI
"A worldwide biotechnology pioneer serving patients with life-changing biologic medicines"
Amgen uses living cells to create biologic medicines that address serious diseases with limited treatment options. The company focuses on four therapeutic areas: oncology, inflammation, general medicine, and rare disease, reaching millions of patients across approximately 100 countries through therapies designed to restore health or save lives. Since 1980, Amgen has built its strategy on a simple belief: innovative, highly differentiated medicines that provide large clinical benefits not only help patients but also reduce the social and economic burden of disease in society, creating value through scientific rigor and patient focus.
31500
Team Members
1980
Founded
Biotechnology
Sector
On-Site
Work Environment
A world where biology unlocks answers to the most challenging diseases, where scientific breakthroughs translate into tangible health outcomes, and where patients suffering from serious illnesses have access to therapies that can restore their lives.
Amgen strives to serve patients by transforming the promise of science and biotechnology into therapies that have the power to restore health or save lives.